Opinion-Based Recommendations: Beware the Tyranny of Experts
Author:
Affiliation:
1. Los Angeles County + University of Southern California Medical Center, Los Angeles, California, USA
2. Division of Pulmonary Critical Care Medicine, MedStar, Washington, District of Columbia, USA
Funder
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Oncology
Link
https://academic.oup.com/ofid/article-pdf/8/11/ofab490/41159968/ofab490.pdf
Reference33 articles.
1. One or three weeks’ treatment of acute pyelonephritis? a double-blind comparison, using a fixed combination of pivampicillin plus pivmecillinam;Jernelius;Acta Med Scand,1988
2. A sequential study of intravenous and oral fleroxacin for 7 or 14 days in the treatment of complicated urinary tract infections;de Gier;Int J Antimicrob Agents,1995
3. Comparison of ciprofloxacin (7 days) and trimethoprim-sulfamethoxazole (14 days) for acute uncomplicated pyelonephritis in women: a randomized trial;Talan;JAMA,2000
4. Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial;Sandberg;Lancet,2012
5. A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis;Peterson;Urology,2008
Cited by 4 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Guidelines for Diagnosis and Management of Infective Endocarditis in Adults;JAMA Network Open;2023-07-31
2. Can the Future of ID Escape the Inertial Dogma of Its Past? The Exemplars of Shorter Is Better and Oral Is the New IV;Open Forum Infectious Diseases;2022-12-29
3. The Role of the Infectious Disease Consultation in Lyme Disease;Infectious Disease Clinics of North America;2022-09
4. Doubts About Guidelines;The Back Letter;2022-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3